INCB18424 in Treating Young Patients With Relapsed or Refractory Solid Tumor, Leukemia, or Myeloproliferative Disease

NCT01164163 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

49

Enrollment

NETWORK

Sponsor class

Conditions

Chronic Myeloproliferative Disorders
Leukemia
Myelodysplastic Syndromes
Myelodysplastic/Myeloproliferative Neoplasms
Unspecified Childhood Solid Tumor, Protocol Specific

Interventions

DRUG: ruxolitinib phosphate
OTHER: laboratory biomarker analysis
OTHER: pharmacological study

Sponsor

Children's Oncology Group

Collaborators

[object Object]